EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION

European Medicines Agency approved apixaban use in cardioversion.

Bibliographic Details
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Series:Рациональная фармакотерапия в кардиологии
Online Access:https://www.rpcardio.com/jour/article/view/268
_version_ 1797659347550994432
collection DOAJ
description European Medicines Agency approved apixaban use in cardioversion.
first_indexed 2024-03-11T18:13:42Z
format Article
id doaj.art-e9b199b1f4de420c881e34da8f9f5ede
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-03-11T18:13:42Z
publishDate 2015-09-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-e9b199b1f4de420c881e34da8f9f5ede2023-10-16T11:31:57ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-01103268EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSIONEuropean Medicines Agency approved apixaban use in cardioversion.https://www.rpcardio.com/jour/article/view/268
spellingShingle EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
Рациональная фармакотерапия в кардиологии
title EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_full EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_fullStr EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_full_unstemmed EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_short EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
title_sort european medicines agency approved apixaban use in cardioversion
url https://www.rpcardio.com/jour/article/view/268